ImpediMed Limited
IPD
Rank in Stocks
#28707
Operating as a medical software technology provider, ImpediMed Limited is... Operating as a medical software technology provider, ImpediMed Limited is responsible for the development, production, and global sales of bioimpedance spectroscopy (BIS) instruments and accompanying software solutions, serving markets in Australia, North America, and internationally. Its product portfolio features SOZO, a non-invasive BIS device used for evaluating lymphedema and tracking fluid levels in heart failure patients. Additionally, it offers the SFB7, a single-channel, tetrapolar BIS instrument for analyzing body composition in healthy individuals, and ImpediVET, another single-channel, tetrapolar BIS device specifically designed for veterinary applications to measure fluid status and tissue composition. ImpediMed primarily sells its technology to hospitals and clinics. This Australian-headquartered firm, based in Pinkenba, was established in 1999.
Share Price
$0.00276876
Last synced: 2026-11-09
Market Cap
$10.15M
Change (1 day)
33.09%
Change (1 year)
-88.53%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade ImpediMed Limited (IPD)
Category
Healthcare
EPS for ImpediMed Limited (IPD)
EPS as of June 2026 TTM: $-0.01
According to ImpediMed Limited's latest financial reports, its current EPS (TTM) is $-0.01. At the end of 2025 the company had an EPS of $-0.01, equal to its 2024 EPS of $-0.01.
EPS history for ImpediMed Limited from 2008 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.01 | -18.00% |
| 2025 | $-0.01 | 13.43% |
| 2024 | $-0.01 | -11.84% |
| 2023 | $-0.01 | -6.17% |
| 2022 | $-0.01 | -37.21% |
| 2021 | $-0.01 | -47.98% |
| 2020 | $-0.02 | -41.78% |
| 2019 | $-0.04 | -13.94% |
| 2018 | $-0.05 | -8.50% |
| 2017 | $-0.05 | -4.75% |
| 2016 | $-0.06 | 39.90% |
| 2015 | $-0.04 | 14.04% |
| 2014 | $-0.04 | -10.33% |
| 2013 | $-0.04 | -47.69% |
| 2012 | $-0.08 | -23.80% |
| 2011 | $-0.10 | 26.56% |
| 2010 | $-0.08 | -35.17% |
| 2009 | $-0.12 | -2.65% |
| 2008 | $-0.12 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -33,026.83% |
US
|
|
| $4.09 | -49,978.05% |
IE
|
|
| $9.45 | -115,343.90% |
US
|
|
| $2.37 | -29,002.44% |
US
|
|
| $1.77 | -21,685.37% |
US
|
Questions about ImpediMed Limited's earnings per share (EPS)
What is ImpediMed Limited's earnings per share (EPS)?
ImpediMed Limited's earnings per share (EPS) over the last twelve months is $-0.01, as of Jun 2026.
What was ImpediMed Limited's earnings per share (EPS) in 2025?
In 2025, ImpediMed Limited's earnings per share (EPS) was $-0.01, compared with $-0.01 in 2024.
How has ImpediMed Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, ImpediMed Limited's earnings per share (EPS) was highest in 2025 ($-0.01) and lowest in 2020 ($-0.02).
How does ImpediMed Limited's earnings per share (EPS) compare with similar companies?
ImpediMed Limited's earnings per share (EPS) ($-0.01) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.